NCT00601978View on ClinicalTrials.gov

Carbidopa/Levodopa Versus Carbidopa/Levodopa/Entacapone on Markers of Event Related Potentials (ERPs) in Patients With Idiopathic Parkinson's Disease (PD) and End-of-dose Wearing Off

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

August 31, 2008

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions
Parkinson's Disease
Interventions
DRUG

carbidopa/levodopa

DRUG

Carbidopa/Levodopa/Entacapone

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY

NCT00601978 - Carbidopa/Levodopa Versus Carbidopa/Levodopa/Entacapone on Markers of Event Related Potentials (ERPs) in Patients With Idiopathic Parkinson's Disease (PD) and End-of-dose Wearing Off | Biotech Hunter | Biotech Hunter